BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

BBIO Stock News

Headlines matching BridgeBio Pharma or the BBIO ticker, most recent first.

  • Barclays Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $157Market news · 30 Sep 2026 · Direct mention
  • TD Cowen Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $110Market news · 24 Sep 2026 · Direct mention
  • BridgeBio (BBIO.US) cardiac therapy acoramidis outperforms Pfizer’s (PFE.US) competitor drug in real-world studyZhitong Finance · 24 Sep 2026 · Direct mention
  • Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $130Market news · 14 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $120Market news · 10 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $110 to $157Market news · 1 Sep 2026 · Direct mention
  • Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $115Market news · 31 Aug 2026 · Direct mention
  • Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $111Market news · 3 Aug 2026 · Direct mention
  • William Blair Maintains BridgeBio Pharma(BBIO.US) With Buy RatingMarket news · 3 Aug 2026 · Direct mention
  • RBC Capital Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100Market news · 14 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $157Market news · 13 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $94 to $115Market news · 12 Aug 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Sagimet Biosciences, Inc. Class A (SGMT), BridgeBio Pharma (BBIO) PositiveTipRanks · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $97 to $115Market news · 11 Aug 2026 · Direct mention
  • Jefferies Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100Market news · 6 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top